Back to search

Demuris Limited

06255507

active
Private Limited Company
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Going concern doubt noted in accounts (-10)

Details

3 WEEKLEY WOOD CLOSE, KETTERING, NN14 1UQ
Incorporated 22/05/2007

Compliance

Last accounts

30/12/2024

full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 22/05/2026

Due 05/06/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Gary D. Glick

director · Since 30/08/2021

CEO

AMERICAN · UNITED STATES · Age 65

Also on 1 other board

Mr Carl Lee Gordon

director · Since 30/08/2021

FOUNDING PARTNER AND GLOBAL CO-HEAD

AMERICAN · UNITED STATES · Age 61

Persons with Significant Control

Odyssey Therapeutics, Inc.

75–100% shares
75–100% votes
Appoint directors
right-to-appoint-and-remove-directors-as-firm

PO BOX 8386, Ann Arbor, Ann Arbor

Reg: N/A · N/A · Delaware Corporation

Notified 30/08/2021

Former PSCs

Newcastle University Holdings Limited

Ceased 30/08/2021

Mr Jeffery Errington

Ceased 30/08/2021

CompanyRankvs 989+ SIC 72110 peers
52

Financial strength67th percentile among SIC peers · 17/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 1.24× · 12/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Cenobiologics Ltd
90
10Ccm Technologies Limited
90
989Demuris Limited
62
How is this score calculated?
Financial strength17/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Material uncertainty related to going concern In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Ba

Key FinancialsYear ending 30/12/2024

Turnover

£13k

Annual revenue

Net Worth

£14k

Balance sheet strength

Cash

£69k

Cash in the bank

Profit Before Tax

£3k

Bottom line earnings

Net Current Assets

£14k

Working capital

Current Assets

£74k

Current Liabilities

£60k

Debtors

£5k

Gross Profit

£13k

Admin Expenses

£10k

Operating Profit

£3k

Profit After Tax

£3k

0avg. employees

Balance Sheet

Assets less current liabilities£14k
Prepared with BTCSoftware AP Solution 2025 12.1.03

EstimatesDerived

YearCurrent RatioImplied Profit
20241.24+£3k
20231.07—

Derived from filed accounts. Not audited figures.